RAY DEBANJAN

Average Profitability
<0.0001%
Insider Buys Quantity
0
Insider Buys Sum
$0
Insider Sells Quantity
19
Insider Sells Sum
$2.94M

Insider Activity of RAY DEBANJAN

The largest sale of all time was on 2018-03-02 and amounted to 38056 shares of CytomX Therapeutics, Inc. for $1.15M.

Biography of RAY DEBANJAN

No biography is available at this moment.

2018-12-12SaleCytomX Therapeutics, Inc.
CTMX
Chief Financial Officer
3,000
0.0066%
$15.00$45,000-31.25%
2018-11-01SaleCytomX Therapeutics, Inc.
CTMX
Chief Financial Officer
3,000
0.0068%
$15.00$45,000-27.27%
2018-10-01SaleCytomX Therapeutics, Inc.
CTMX
Chief Financial Officer
3,000
0.0066%
$18.46$55,380-40.52%
2018-09-04SaleCytomX Therapeutics, Inc.
CTMX
Chief Financial Officer
3,000
0.0069%
$22.39$67,170-46.83%
2018-08-01SaleCytomX Therapeutics, Inc.
CTMX
Chief Financial Officer
3,000
0.0067%
$26.05$78,150-47.6%
2018-07-02SaleCytomX Therapeutics, Inc.
CTMX
Chief Financial Officer
3,000
0.0065%
$22.56$67,680-37.57%
2018-06-01SaleCytomX Therapeutics, Inc.
CTMX
Chief Financial Officer
6,000
0.0082%
$13.60$81,573-36.66%
2018-05-01SaleCytomX Therapeutics, Inc.
CTMX
Chief Financial Officer
6,000
0.008%
$13.89$83,342-35.52%
2018-04-02SaleCytomX Therapeutics, Inc.
CTMX
Chief Financial Officer
6,000
0.0081%
$14.69$88,140-32.56%
2018-03-02SaleCytomX Therapeutics, Inc.
CTMX
Chief Financial Officer
38,056
0.0899%
$30.34$1.15M-32.69%
2018-03-01SaleCytomX Therapeutics, Inc.
CTMX
Chief Financial Officer
26,000
0.0347%
$15.33$398,620-24.43%
2018-02-01SaleCytomX Therapeutics, Inc.
CTMX
Chief Financial Officer
5,096
0.0129%
$26.69$136,020-14.86%
2018-01-02SaleCytomX Therapeutics, Inc.
CTMX
Chief Financial Officer
5,000
0.0126%
$21.11$105,550+12.5%
2017-12-01SaleCytomX Therapeutics, Inc.
CTMX
Chief Financial Officer
5,000
0.0126%
$20.58$102,900+16.24%
2017-11-01SaleCytomX Therapeutics, Inc.
CTMX
Chief Financial Officer
5,000
0.013%
$20.00$100,000+22.74%
2017-10-02SaleCytomX Therapeutics, Inc.
CTMX
Chief Financial Officer
5,000
0.0122%
$18.10$90,500+27.01%
2017-09-01SaleCytomX Therapeutics, Inc.
CTMX
Chief Financial Officer
5,000
0.0132%
$17.17$85,850+39.01%
2017-08-09SaleCytomX Therapeutics, Inc.
CTMX
Chief Financial Officer
5,000
0.0141%
$15.00$75,000+69.79%
2017-07-03SaleCytomX Therapeutics, Inc.
CTMX
Chief Financial Officer
5,000
0.0132%
$15.47$77,350+41.33%
Prismo does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. Prismo does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.